30.08.2018 MeVis Medical Solutions AG  DE000A0LBFE4

DGAP-Adhoc: MeVis Medical Solutions AG: Raising forecast for the current fiscal year


 
DGAP-Ad-hoc: MeVis Medical Solutions AG / Key word(s): Change in Forecast MeVis Medical Solutions AG: Raising forecast for the current fiscal year 30-Aug-2018 / 15:51 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Bremen, August 30, 2018 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, raises its forecast for the present fiscal year due to the positive business development: * For fiscal year 2018 (October 1, 2017 to September 30, 2018) a significant decrease in revenues to EUR 16.0 million to EUR 16.5 million is now expected (previous forecast for fiscal year 2018: significant decrease to EUR 14.5 million to EUR 15.0 million). * For fiscal year 2018 (October 1, 2017 to September 30, 2018) a significant decrease in the EBIT (earnings before interest and taxes) is expected to EUR 5.5 million to EUR 6.0 million (previous forecast for fiscal year 2018: decrease in EBIT to EUR 3.0 million to EUR 3.5 million). ************************************************************************ Contact: Dr. Hannemann, Robert / CFO --------------------------------------------------------------------------- 30-Aug-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: MeVis Medical Solutions AG Caroline-Herschel-Str. 1 28359 Bremen Germany Phone: +49 421 224 95 0 Fax: +49 421 224 95 999 E-mail: [email protected] Internet: http://www.mevis.de ISIN: DE000A0LBFE4 WKN: A0LBFE Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange End of Announcement DGAP News Service --------------------------------------------------------------------------- 719191 30-Aug-2018 CET/CEST


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023
Umsatzerlöse1 18,54 16,76 18,07 17,13 16,21 18,76 17,34
EBITDA1,2 9,18 7,60 8,25 5,97 4,77 7,99 3,99
EBITDA-Marge3 49,51 45,35 45,66 34,85 29,43 42,59
EBIT1,4 7,96 6,69 8,00 5,81 4,64 7,90 3,89
EBIT-Marge5 42,93 39,92 44,27 33,92 28,62 42,11 22,43
Jahresüberschuss1 5,62 7,17 8,07 5,70 4,55 7,79 4,92
Netto-Marge6 30,31 42,78 44,66 33,27 28,07 41,52 28,37
Cashflow1,7 7,32 5,52 6,55 2,89 9,13 4,86 5,85
Ergebnis je Aktie8 3,09 3,94 4,43 3,13 2,50 4,28 2,70
Dividende8 0,95 0,95 0,95 0,95 0,95 0,95 0,95
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Deloitte

INVESTOR-INFORMATIONEN
©boersengefluester.de
MeVis Med. Solutions
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A0LBFE 25,200 Halten 45,86
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
10,50 10,26 1,00 7,68
KBV KCV KUV EV/EBITDA
2,57 7,83 2,64 10,70
Dividende '22 in € Dividende '23 in € Div.-Rendite '23
in %
Hauptversammlung
0,95 0,95 3,77 19.03.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
- 27.05.2025 - 30.01.2025
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
5,34% 0,58% 0,00% -5,26%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu MeVis Medical Solutions AG  ISIN: DE000A0LBFE4 können Sie bei EQS abrufen


Medtech , A0LBFE , M3V , XETR:M3V